Migdal Insurance & Financial Holdings’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-370
| Closed | -$42K | – | 756 |
|
2020
Q3 | $42K | Buy |
+370
| New | +$42K | ﹤0.01% | 578 |
|
2020
Q1 | – | Sell |
-1,531
| Closed | -$166K | – | 802 |
|
2019
Q4 | $166K | Sell |
1,531
-44
| -3% | -$4.77K | ﹤0.01% | 444 |
|
2019
Q3 | $154K | Buy |
1,575
+272
| +21% | +$26.6K | ﹤0.01% | 504 |
|
2019
Q2 | $171K | Buy |
+1,303
| New | +$171K | ﹤0.01% | 493 |
|
2018
Q4 | – | Sell |
-1,590
| Closed | -$221K | – | 830 |
|
2018
Q3 | $221K | Buy |
1,590
+942
| +145% | +$131K | ﹤0.01% | 507 |
|
2018
Q2 | $80K | Buy |
648
+628
| +3,140% | +$77.5K | ﹤0.01% | 542 |
|
2018
Q1 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 623 |
|